Yale and CT Pharma to conduct new clinical study on medical marijuana

New Haven

(WTNH) — A study exploring the effectiveness of medical marijuana on stress and pain will soon begin in Connecticut.

The Department of Consumer Protection, Yale School of Medicine and CT Pharma are joining together on phase one of the study.

It’s the first of its kind on human subjects.

Researchers want to understand the positives and negatives of using medical marijuana, and want to pinpoint it’s therapeutic potential.

Medical marijuana was legalized in Connecticut to treat 11 specific conditions. Since then, it has expanded to 36 conditions, and 10 for kids under 18.

Copyright 2020 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

New Haven

Milford Police officer named Nationwide D.A.R.E. Officer of the Year

News /

2020 NHdocs to go on amid pandemic

News /

Will it stay or go? Future of Waterbury Columbus statue to be on November ballot

News /

Yale researchers out with results of study on what went wrong inside CT nursing homes amid peak of COVID-19 pandemic

News /

Luxury apartments could be built on CT Post Mall property

News /

Feds accuse Yale of discriminating against some applicants

News /
More New Haven

Don't Miss

More Don't Miss